Examining bone health changes after osteoporosis treatment
Changes of Bone Turnover Markers and Bone Mineral Density After Treatment in Osteoporotic Patients
This study tests whether Bonviva and vitamin D can improve bone health in people with osteoporosis by looking at changes in bone density over time.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 20 Years to 100 Years |
| Sex | All |
| Sponsor | Shinshu University Academic / other |
| Locations | 1 site (Komagane, Nagano) |
| Trial ID | NCT02156999 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of Bonviva treatment on bone mineral density and bone turnover markers in patients diagnosed with osteoporosis. It involves administering Ibandronic acid and vitamin D to assess their impact on bone health over time. The study aims to provide insights into how these treatments can improve bone density and overall patient outcomes. Participants will be monitored for changes in their bone health indicators throughout the treatment period.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with osteoporosis.
Not a fit: Patients with kidney issues, parathyroid disorders, or congenital bone metabolic diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for osteoporosis, enhancing bone health and reducing fracture risk in patients.
How similar studies have performed: Other studies have shown positive outcomes with similar treatments for osteoporosis, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Osteoporosis Exclusion Criteria: * Kidney, parathyroid, congenital bone metabolic disease
Where this trial is running
Komagane, Nagano
- Showa Inan General Hospital — Komagane, Nagano, Japan (Recruiting)
Study contacts
- Study coordinator: Yukio Nakamura, MD, PhD
- Email: yxn14@aol.jp
- Phone: +81-263-37-2659
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.